Moleculin Biotech, Inc.
5300 Memorial Drive, Suite 950
Houston, TX 77007
January 2, 2026
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
Washington, DC 20549
Attention: Jessica Dickerson
| Re: | Moleculin Biotech, Inc. |
|
Registration Statement on Form S-1 Registration No. 333-292420 |
|
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Moleculin Biotech, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 P.M. (Eastern Time) on January 6, 2026, or as soon thereafter as possible on such date.
|
Very truly yours,
Moleculin Biotech, Inc. |
|
|
By: /s/ Jonathan P. Foster Name: Jonathan P. Foster Title: Chief Financial Officer |
|